Regulation of the stimulant actions of neurokinin A and human hemokinin-1 on the human uterus: A comparison with histamine

Biology of Reproduction

Volumn 75, Issue 3, 2006, Pages 334-341

  Pennefather, Jocelyn N ^a,b   Patak, Eva ^a   Ziccone, Sebastian ^a   Lilley, Alison ^a   Pinto, Francisco M ^c   Page, Nigel M ^d   Story, Margot E ^b   Grover, Sonia ^e,f   Candenas, M Luz ^d,g  

^a ROYAL WOMEN'S HOSPITAL   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c INSTITUTO DE INVESTIGACIONES QUÍMICAS   (Spain)

^d KINGSTON UNIVERSITY   (United Kingdom)

^e MERCY HOSPITAL FOR WOMEN   (Australia)

^f UNIVERSITY OF MELBOURNE   (Australia)

^g CSIC JA USE Centro de Investigaciones Cientificas Isla de la Cartuja CICIC   (Spain)

Author keywords

Lys5MeLeu9Nle10 NKA(4 10); Eledoisin; Endokinin; Female reproductive tract; Hemokinin; Histamine; Human myometrium; Neprilysin; Neurokinin A; Neuropeptides; NK1 and NK2 receptors; Pregnancy

Indexed keywords

ELEDOISIN; ENDOKININ D; HEMOKININ 1; HISTAMINE; KININ DERIVATIVE; MEMBRANE METALLOENDOPEPTIDASE; MEPYRAMINE; NEUROKININ 1 RECEPTOR ANTAGONIST; NEUROKININ 2 RECEPTOR; NEUROKININ 2 RECEPTOR AGONIST; NEUROKININ 2 RECEPTOR ANTAGONIST; NEUROKININ A; NEUROKININ A [4-10]; NEUROKININ A [4-10][5 LYSINE 9 METHYLLEUCINE 10 NORLEUCINE]; NEUROKININ A DERIVATIVE; NOLPITANTIUM; PEPTIDE; POTASSIUM; REAGENT; REGULATOR PROTEIN; SAREDUTANT; TACHYKININ; UNCLASSIFIED DRUG; UTEROTONIC AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN TISSUE; HYSTERECTOMY; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; MENSTRUATION DISORDER; MYOMETRIUM; PREGNANCY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR BLOCKING; UTERUS BIOPSY; UTERUS CONTRACTILITY;

DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HISTAMINE; HISTAMINE ANTAGONISTS; HUMANS; MAST CELLS; MYOMETRIUM; NEPRILYSIN; NEUROKININ A; POTASSIUM; PREGNANCY; PROTEASE INHIBITORS; RECEPTORS, NEUROKININ-2; RECEPTORS, TACHYKININ; TACHYKININS; UTERINE CONTRACTION; UTERUS;

MAMMALIA;

EID: 33747598002     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod.106.051508     Document Type: Article

References (42)

1. Pennefather JN, Patak E, Pinto FM, Candenas ML. Mammalian tachykinins and uterine smooth muscle: the challenge escalates. Eur J Pharmacol 2004; 500:15-26.
2. Page NM. Hemokinins and endokinins. Cell Mol Life Sci 2004; 61:1652-1663.
3. Pennefather JN, Lecci A, Candenas ML, Patak E, Pinto FM, Maggi CA. Tachykinins and tachykinin receptors: a growing family. Life Sci 2004; 74:1445-1463.
4. Patacchini R, Lecci A, Holzer P, Maggi CA. Newly discovered tachykinins raise new questions about their peripheral roles and the tachykinin nomenclature. Trends Pharmacol Sci 2004; 25:1-3.
5. Page NM, Bell NJ, Gardiner SM, Manyonda IT, Brayley KJ, Strange PG, Lowry PJ. Characterization of the endokinins: human tachykinins with cardiovascular activity. Proc Natl Acad Sci U S A 2003; 100:6245-250.
6. Patak EN, Pennefather JN, Story ME. Effects of tachykinins on uterine smooth muscle. Clin Exp Pharmacol Physiol 2000; 27:922-927.
7. Candenas L, Lecci A, Pinto FM, Patak E, Maggi CA, Pennefather JN. Tachykinins and tachykinin receptors: effects in the genitourinary tract. Life Sci 2005; 76:835-862.
8. Arck PC, Merali FS, Stanisz AM, Stead RH, Chaouat G, Manuel J, Clark DA. Stress-induced murine abortion associated with substance P-dependent alteration in cytokines in maternal uterine decidua. Biol Reprod 1995; 53:814-819.
9. Fisher L, Pennefather JN, Hall S. Tachykinin receptors in the rat isolated uterus. Regul Pept 1993; 46:396-398.
10. Fisher L, Pennefather JN. Potencies of agonists acting at tachykinin receptors in the oestrogen-primed rat uterus: effects of peptidase inhibitors. Eur J Pharmacol 1997; 335:221-226.
11. Hamlin GP, Williams MJ, Nimmo AJ, Crane LH. Hormonal variation of rat uterine contractile responsiveness to selective neurokinin receptor agonists. Biol Reprod 2000; 62:1661-1666.
12. Schmidt C, Lobos E, Spanel-Borowski K. Pregnancy-induced changes in substance P and neurokinin 1 receptor (NK1-R) expression in the rat uterus. Reproduction 2003; 126:451-458.
13. Patak E, Pinto FM, Story ME, Pintado CO, Fleming A, Page NM, Pennefather JN, Candenas ML. Functional and molecular characterization of tachykinins and tachykinin receptors in the mouse uterus. Biol Reprod 2005; 72:1125-1133.
14. 2 receptors by tachykinin peptides causes contraction of uterus in pregnant women near term. Mol Hum Reprod 2000; 6:549-554.
15. Patak E, Candenas ML, Pennefather JN, Ziccone S, Lilley A, Martín JD, Flores C, Mantecón AG, Story ME, Pinto FM. Tachykinins and tachykinin receptors in human uterus. Br J Pharmacol 2003; 139:523-532.
16. Regoli D, Boudon A, Fauchere JL. Receptors and antagonists for substance P and related peptides. Pharmacol Rev 1994; 46:551-599.
17. Lecci A, Giuliani S, Tramontana M, Carini F, Maggi CA. Peripheral actions of tachykinins. Neuropeptides 2000; 34:303-313.
18. Emonds-Alt X, Vilain P, Goulaonie P, Proietto V, Van Broeck D, Advenier C, Naline E, Neliat G, Le Fur G, Breliere JC. A potent and selective non-peptide antagonist of the neurokinin A (NK2) receptor. Life Sci 1992; 50:L101-L106.
19. Matsas R, Kenny AJ, Turner AJ. The metabolism of neuropeptides. The hydrolysis of peptides, including enkephalins, tachykinins and their analogues, by endopeptidase-24.11. Biochem J 1984; 223:433-440.
20. Hooper NM, Kenny AJ, Turner AJ. The metabolism of neuropeptides. Neurokinin A (substance K) is a substrate for endopeptidase-24.11 but not for peptidyl dipeptidase A (angiotensin-converting enzyme). Biochem J 1985; 231:357-361.
21. Hooper NM, Turner AJ. Neurokinin B is hydrolysed by synaptic membranes and by endopeptidase-24.11 (enkephalinase) but not by angiotensin converting enzyme. FEBS Lett 1985; 190:133-136.
22. Martinez-Mir MI, Estan L, Morales-Olivas FJ, Rubio E. Effect of histamine and histamine analogues on human isolated myometrial strips. Br J Pharmacol 1992; 107:528-531.
23. Rudolph MI, Reinicke K, Cruz MA, Gallardo V, Gonzalez C, Bardisa L. Distribution of mast cells and the effect of their mediators on contractility in human myometrium. Br J Obstet Gynaecol 1994; 100:1125-1130.
24. Szukiewicz D, Maslinska D, Stelmachow J, Wojtecka-Lukasik E. Biogenetic amines in placental tissue. Relation to the contractile activity of the human uterus. Preliminary communication. Clin Exp Obstet Gynecol 1995; 22:66-70.
25. Schrey MP, Hare AL, Ilson SL, Walters MP. Decidual histamine release and amplification of prostaglandin F2 alpha production by histamine in interleukin-1 beta-primed decidual cells: potential interactive role for inflammatory mediators in uterine function at term. J Clin Endocrinol Metab 1995; 80:648-653.
26. Bytautiene E, Romero R, Vedernikov YP, El-Zeky F, Saade GR, Garfield RE. Induction of premature labor and delivery by allergic reaction and prevention by histamine H1 receptor antagonist. Am J Obstet Gynecol 2004; 191:1356-1361.
27. 1 receptor antagonist. Eur J Pharmacol 1993; 250:403-413.
28. 3 receptor. Life Sci 1995; 56:L27-L32.
29. Motulsky HJ, Christopoulos A. Fitting dose-response curves. In: Fitting Models to Biological Data using Linear and Nonlinear Regression. A Practical Guide to Curve Fitting. San Diego: GraphPad Software Inc 2003256-295.
30. Kwok R, Nassel DR, Lange AB, Orchard I. Locustatachykinin isoforms in the locust: distribution and quantification in the central nervous system and action on the oviduct muscle. Peptides 1999; 20:687-694.
31. Satake H, Ogasawara M, Kawada T, Masuda K, Aoyama M, Minakata H, Chiba T, Metoki H, Satou Y, Satoh N. Tachykinin and tachykinin receptor of an ascidian, Ciona intestinalis: evolutionary origin of the vertebrate tachykinin family. J Biol Chem 2004; 279:53798-53805.
32. Debeljuk L, Lasaga M. Modulation of the hypothalamo-pituitary-gonadal axis and the pineal gland by neurokinin A, neuropeptide K and neuropeptide gamma. Peptides 1999; 20:285-299.
33. Severini C, Improta G, Falconieri-Erspamer G, Salvadori S, Erspamer V. The tachykinin peptide family. Pharmacol Rev 2002; 54:285-322.
34. Bellucci F, Carini F, Catalani C, Cucchi P, Lecci A, Meini S, Patacchini R, Quartara L, Ricci R, Tramontana M, Giuliani S, Maggi CA. Pharmacological profile of the novel mammalian tachykinin, hemokinin 1. Br J Pharmacol 2002; 135:266-274.
35. Camarda V, Rizzi A, Calo G, Guerrini R, Salvadori S, Regoli D. Pharmacological profile of hemokinin 1: a novel member of the tachykinin family. Life Sci 2002; 71:363-370.
36. Bellucci F, Meini S, Catalioto RM, Catalani C, Giuliani S, Quartara L, Giolitti A, Faiella A, Rotondaro L, Candenas ML, Pinto FM, Maggi CA. Pharmacological evaluation of alpha and beta human tachykinin NK(2) receptor splice variants expressed in CHO cells. Eur J Pharmacol 2004; 499:229-238.
37. Wray S. Uterine contraction and physiological mechanisms of modulation. Am J Physiol 1993; 264:C1-C18.
38. Tezuka N, Ali M, Chwalisz K, Garfield RE. Changes in transcripts encoding calcium channel subunits of rat myometrium during pregnancy. Am J Physiol 1995; 269:C1008-C10017.
39. Trujillo M, Candenas L, Cintado CG, Magraner J, Fernandez J, Martin JD, Pinto FM. Hormonal regulation of the contractile response induced by okadaic acid in the rat uterus. J Pharmacol Exp Ther 2001; 296:841-848.
40. Fuchs AR, Fuchs F, Husslein P, Soloff MS. Oxytocin receptors in the human uterus during pregnancy and parturition. Am J Obstet Gynecol 1984; 150:734-741.
41. Kimura T, Takemura M, Nomura S, Nobunaga T, Kubota Y, Inoue T, Hashimoto K, Kumazawa I, Ito Y, Ohashi K, Koyama M, Azuma C, et al. Expression of oxytocin receptor in human pregnant myometrium. Endocrinology 1996; 137:780-785.
42. Massey WA, Guo CB, Dvorak AM, Hubbard WC, Bhagavan BS, Cohan V, Warner JA, Kagey-Sobotka A, Lichtenstein LM. Human uterine mast cells. Isolation, purification, characterization, ultrastructure, and pharmacology. J Immunol 1991; 147:1621-1627.